ArticleMycotoxin research2025
Co-occurrence and risk assessment of ochratoxin A and deoxynivalenol in tortillas.
Article in Mycotoxin research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alcoholic beer fermentation: impact of glutathione and peroxidase fortification on deoxynivalenol reduction.Mycotoxin research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The presence of mycotoxins, including ochratoxin A (OTA) and deoxynivalenol (DON), in tortillas raises potential food safety concerns, particularly in regions where these products constitute a dietary staple. In the present study, the natural occurrence and concentrations of OTA and DON were determined in commercially available tortillas in Turkey. A total of 84 tortilla samples were analysed using an in-house validated high-performance liquid chromatography (HPLC) method. OTA was detected in 25% of the samples, with concentrations ranging from 0.079 to 0.93 µg/kg, all of which remained below the European Union maximum level (EU ML) of 3 µg/kg. DON was found in 10.7% of the samples, with concentrations between 13.1 and 158 µg/kg, also within the EU ML of 400 µg/kg. Co-occurrence of OTA and DON was observed in three samples. These findings highlight considered variability among products, likely attributable to differences in raw material quality, environmental conditions, and post-harvest handling practices. This variability underscores the need for enhanced regulatory surveillance, improved storage conditions, and the implementation of optimised processing technologies. Furthermore, the estimated dietary exposure levels for both OTA and DON were found to pose no significant health risks under current consumption patterns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.